RankAlpha logo
Back to Rankings

KMDA

KamadaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The Q2 print supports a positive operating trajectory: record revenue, adjusted EBITDA and cash generation, with revenue and EBITDA approximately at 50% of the respective FY2026 guidance midpoints. The plasma agreement, dividend, MENA and biosimilar expansion, and CYTOGAM research provide multiple sources of potential longer-term support.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Back-end-loaded FY2026 guidance depends on continued demand and successful second-half execution.
Momentum
28
Value
66
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.50 · Bull $11.50 · Bear $6.25Analysis 2026-08-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-17 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $13.50
Why
Momentum28 · Δ7d -
Value66 · Δ7d 0.0
Sentiment68 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • • Back-end-loaded FY2026 guidance depends on continued demand and successful second-half execution.
  • • Biosimilar launches, MENA distribution expansion and M&A or business-development activity may not convert into revenue on schedule.
  • • Management reaffirmed rather than raised guidance despite strong first-half results.

Catalyst clock

2026-08-12

Q2 earnings beat with FY2026 guidance reaffirmed

Lead driver: Sentiment · See AI snapshot
Momentum
28
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
66
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+1.1
Sentiment
68
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 28.1 / Value 66.2 / Sentiment 68.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-17. Scenario method

B+
Bull case
20%
Probability
Target price
$11.50
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Most likely
B
Base case
55%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$6.25
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$444.45M
Beta
0.94
Shares Out
57.69M
P/E (TTM)
20.6
P/S (TTM)
2.39
P/FCF (TTM)
22.79
Rev YoY
+22.7%
EPS YoY
+25.1%
Gross Margin
+40.8%
Op Margin
+14.5%
Net Debt
-$63.91M
Current Ratio
4.06
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data